New Shared Care Agreement: Methotrexate for Dermatology Indications
A new Shared Care Agreement (SCA) for subcutaneous methotrexate has been approved for use in adult patients with psoriasis or eczema and other inflammatory skin conditions.
The SCA and associated letter template are available on the SCA webpage.
Published 23/02/2022. Medicines Update blogs are correct at the time of publication.